Livestock raised in confined animal feeding operations (CAFOs) are routinely given a range of veterinary drugs to prevent disease, and some of those drugs could potentially impact the health of those who eat their meat. November 7, 2023, the U.S. Food and Drug Administration announced it is considering withdrawing approval for the antibiotic carbadox1 (brand… Read More »
Early results from a small study suggest that six-monthly injections of lenacapavir, an experimental HIV capsid inhibitor, can be used as part of a combination regimen for people starting HIV treatment, the 11th International AIDS Society Conference on HIV Science (IAS 2021) heard today. On Saturday, aidsmap reported on CAPELLA, a study of lenacapavir in treatment-experienced people failing… Read More »
BALTIMORE, July 1, 2021 /PRNewswire/ –Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin), announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis in adults. Trichomoniasis… Read More »
Just a few short months after Johnson & Johnson’s Janssen unit sent its targeted non-small cell lung cancer drug amivantamab to the FDA, the regulator has come back with a green light—a very specific one. Now christened Rybrevant, the drug is the first-ever treatment for non-small cell lung cancer with a group of epidermal growth factor receptor (EGFR) mutations found in… Read More »